Fig. 5.
Effect of Hsp90 ATPase inhibitor in diseased state on Akt1 and Cyclin D1 levels. The above graph shows the fold decrease in the active Akt-1 and Raf-1P levels in presence 1 μM of the inhibitor during disease
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.